These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3492510)

  • 1. Towards a behavioral typology of Alzheimer's patients.
    Martin A; Brouwers P; Lalonde F; Cox C; Teleska P; Fedio P; Foster NL; Chase TN
    J Clin Exp Neuropsychol; 1986 Oct; 8(5):594-610. PubMed ID: 3492510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
    Friedland RP; Budinger TF; Koss E; Ober BA
    Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and cerebral metabolic function in early and advanced Alzheimer's disease.
    Chase TN; Foster NL; Fedio P; Mansi L; Brooks R; Kessler R; Di Chiro G
    Monogr Neural Sci; 1984; 11():176-9. PubMed ID: 6610824
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
    Foster NL; Chase TN; Patronas NJ; Gillespie MM; Fedio P
    Ann Neurol; 1986 Feb; 19(2):139-43. PubMed ID: 3485952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
    McGeer EG; Peppard RP; McGeer PL; Tuokko H; Crockett D; Parks R; Akiyama H; Calne DB; Beattie BL; Harrop R
    Can J Neurol Sci; 1990 Feb; 17(1):1-11. PubMed ID: 2311010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
    Cutler NR; Haxby JV; Duara R; Grady CL; Moore AM; Parisi JE; White J; Heston L; Margolin RM; Rapoport SI
    Neurology; 1985 Nov; 35(11):1556-61. PubMed ID: 3877253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.
    Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Di Chiro G
    Ann Neurol; 1984; 15 Suppl():S170-4. PubMed ID: 6611118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E; Friedland RP; Ober BA; Jagust WJ
    Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's dementia.
    Chase TN; Tamminga CA
    Am J Psychiatry; 1995 Aug; 152(8):1110. PubMed ID: 7625456
    [No Abstract]   [Full Text] [Related]  

  • 20. Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
    Tune L; Brandt J; Frost JJ; Harris G; Mayberg H; Steele C; Burns A; Sapp J; Folstein MF; Wagner HN
    Acta Psychiatr Scand Suppl; 1991; 366():61-5. PubMed ID: 1897377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.